Octreotide | Teva UK
For patients and members of the public:

Octreotide

Overview

The Patient Information Leaflet for products containing Octreotide from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. To contact Teva's Medical Information Service email: medinfo@tevauk.com or telephone: 0207 540 7117.

Available as
  • Powder for Injection

Date of preparation: February 2022
Reference: COB-GB-NP-00077

Date of preparation: February 2022
Reference: COB-GB-00006